Avidity Biosciences Statistics
Total Valuation
RNA has a market cap or net worth of $5.08 billion. The enterprise value is $3.63 billion.
Important Dates
The last earnings date was Thursday, November 7, 2024, after market close.
Earnings Date | Nov 7, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
RNA has 119.31 million shares outstanding. The number of shares has increased by 44.08% in one year.
Current Share Class | 119.31M |
Shares Outstanding | 119.31M |
Shares Change (YoY) | +44.08% |
Shares Change (QoQ) | +15.38% |
Owned by Insiders (%) | 0.41% |
Owned by Institutions (%) | 87.65% |
Float | 92.43M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | 238.97 |
PB Ratio | 3.45 |
P/TBV Ratio | 3.41 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 358.49 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 17.76, with a Debt / Equity ratio of 0.01.
Current Ratio | 17.76 |
Quick Ratio | 17.60 |
Debt / Equity | 0.01 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -27.76% and return on invested capital (ROIC) is -19.90%.
Return on Equity (ROE) | -27.76% |
Return on Assets (ROA) | -18.33% |
Return on Capital (ROIC) | -19.90% |
Revenue Per Employee | $39,988 |
Profits Per Employee | -$1.11M |
Employee Count | 253 |
Asset Turnover | 0.01 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +621.44% in the last 52 weeks. The beta is 0.91, so RNA's price volatility has been similar to the market average.
Beta (5Y) | 0.91 |
52-Week Price Change | +621.44% |
50-Day Moving Average | 45.42 |
200-Day Moving Average | 35.00 |
Relative Strength Index (RSI) | 44.89 |
Average Volume (20 Days) | 1,107,147 |
Short Selling Information
Short Interest | 14.66M |
Short Previous Month | 14.88M |
Short % of Shares Out | 15.15% |
Short % of Float | n/a |
Short Ratio (days to cover) | 17.70 |
Income Statement
In the last 12 months, RNA had revenue of $10.12 million and -$280.49 million in losses. Loss per share was -$2.85.
Revenue | 10.12M |
Gross Profit | -250.67M |
Operating Income | -324.69M |
Pretax Income | -228.68M |
Net Income | -280.49M |
EBITDA | -322.04M |
EBIT | -324.69M |
Loss Per Share | -$2.85 |
Full Income Statement Balance Sheet
The company has $1.59 billion in cash and $7.60 million in debt, giving a net cash position of $1.58 billion or $13.25 per share.
Cash & Cash Equivalents | 1.59B |
Total Debt | 7.60M |
Net Cash | 1.58B |
Net Cash Per Share | $13.25 |
Equity (Book Value) | 1.50B |
Book Value Per Share | 12.64 |
Working Capital | 1.53B |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$184.50 million and capital expenditures -$4.01 million, giving a free cash flow of -$188.51 million.
Operating Cash Flow | -184.50M |
Capital Expenditures | -4.01M |
Free Cash Flow | -188.51M |
FCF Per Share | -$1.58 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | -3,209.34% |
Pretax Margin | -2,772.44% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | -1,322.91% |
Dividends & Yields
RNA does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -44.08% |
Shareholder Yield | -44.08% |
Earnings Yield | -5.46% |
FCF Yield | -3.67% |
Analyst Forecast
The average price target for RNA is $63.22, which is 48.54% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $63.22 |
Price Target Difference | 48.54% |
Analyst Consensus | Strong Buy |
Analyst Count | 9 |
Revenue Growth Forecast (5Y) | 146.17% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
RNA has an Altman Z-Score of 10.13 and a Piotroski F-Score of 2.
Altman Z-Score | 10.13 |
Piotroski F-Score | 2 |